pharmaceutical composition, sealed container, metered dose inhaler, and methods for treating a patient suffering or likely to suffer from a respiratory disorder, for improving the stability of a pharmaceutical composition, for improving aerosol dispersion performance of a pharmaceutical composition and to reduce the global warming potential of a pharmaceutical composition.

摘要

It is a pharmaceutical composition. the composition comprises: (i) a drug component comprising at least one pharmaceutically acceptable salt of glycopyrrolate; and (ii) a propellant component comprising 1,1-difluoroethane (hfa-152a).